Pasadena Private Wealth, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
Pasadena Private Wealth, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2023$6,675
-3.0%
10,5960.0%0.00%0.0%
Q4 2022$6,878
-61.8%
10,5960.0%0.00%
-66.7%
Q3 2022$18,000
+38.5%
10,5960.0%0.01%
+50.0%
Q2 2022$13,000
+85.7%
10,5960.0%0.00%
+100.0%
Q1 2022$7,000
-41.7%
10,5960.0%0.00%
-50.0%
Q4 2021$12,000
-36.8%
10,5960.0%0.00%
-42.9%
Q3 2021$19,00010,5960.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders